VUNO

VUNO is a Korean medical-AI company whose diagnostic models analyze medical images and biosignals to support clinicians in radiology, endoscopy and emergency care.

Overview

Publicly listed in Korea, VUNO builds deep-learning products that detect findings in chest CT, bone age studies, endoscopic video and even voice. Its portfolio includes tools that quantify pulmonary nodules, predict cardiac arrest risk from vital signs and assist endoscopists in real time, all designed to slot into hospital workflows. VUNO works closely with Korean hospitals on clinical validation and exports its technology to healthcare partners across Asia.

Key Features

• Chest CT analysis for pulmonary nodule detection and quantification
• Endoscopy AI that flags suspicious lesions during procedures
• Voice-based health screening research and products
• Vital-sign analytics for emergency deterioration prediction
• Hospital system integration with PACS and EMR platforms
• Clinical studies and regulatory approvals across Asian markets

Pricing

VUNO products are licensed to hospitals and medical institutions through commercial agreements; pricing depends on product mix, deployment and study volume.

Who Is It For

Hospitals, screening centers and health systems in Asia that want clinically validated AI assistance across imaging and patient monitoring.

Use Cases

VUNO fits hospitals that want AI assistance across several departments rather than a single detection task.

• Pulmonary nodule detection and tracking on chest CT
• Real-time assistance during endoscopic procedures
• Early-warning scoring from bedside vital signs

Getting Started

Deployments begin with clinical evaluation on site: VUNO integrates with imaging and monitoring systems, then radiologists and clinicians validate results before go-live.

Results to Expect

Clinics gain consistent second opinions and faster triage, with the convenience of a single vendor covering multiple modalities and use cases.

Implementation and Support

Deployments integrate with hospital imaging and monitoring systems, followed by clinical validation and staff training. VUNO’s team supports each product module during rollout.

Limitations to Keep in Mind

Regulatory clearance varies by product and country, and AI findings always require clinician confirmation.

What Users Say

Hospitals value having one vendor cover imaging, endoscopy and biosignal use cases consistently.

FAQ

Is VUNO free to use?

No. VUNO’s clinical products are commercial medical software; institutions arrange demonstrations and pilots through its business team.

Does VUNO offer an API?

Deployment is handled through hospital imaging and clinical systems, with integration terms defined per installation.

How does VUNO compare to alternatives?

VUNO differentiates with a broad multimodal lineup — imaging, biosignal and voice — under one vendor, which suits hospitals consolidating AI procurement.